PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NAPRx®

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

NAPSR Named as Official Media Partner for Pharmaforce 2006 - The NAPSR® is a trade association for thousands of pharmaceutical sales representatives
NAPSR Named as Official Media Partner for Pharmaforce 2006

 

NewswireToday - /newswire/ - Washington, DC, United States, 2006/10/06 - The NAPSR® is a trade association for thousands of pharmaceutical sales representatives.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The National Association of Pharmaceutical Sales Representatives is proud to announce its agreement as an Official Media Partner with PharmaForce International. PharmaForce International is the global leader in pharmaceutical sales, marketing and medical benchmarking.

Pharmaceutical and biotech companies throughout the world utilize PharmaForce’s syndicated industry studies and proprietary research capabilities to better evaluate competitors, allocate marketing resources, maximize the success of product launches and communicate with all customer constituencies.

At PharmaForce 2006, you will gain strategic insight into overcoming your sales strategy challenges and ensure you walk away with usable strategies to boost the ROI of your sales force while remaining compliant in this highly competitive environment.

All NAPSR members gain a 15% discounted rate by using code XM99.

Key industry leaders you will hear from Include:
• Geno Germano, Executive Vice President & General Manager, Pharmaceutical Business Unit, Wyeth
• Michael Capaldi, Associate Vice President, Sales Training & Development, Sanofi-Aventis
• Margaret Ellis, VP National & Regional Accounts Management, Johnson & Johnson Healthcare
• Curtis Staab, Senior Director, Sales Operations, Merck
• Lesley MacKellar, Associate Training Consultant, Global Training & Capabilities, Eli Lilly

Key themes:
• Sales Force Optimization – Gain insights and maximize your ROI
• Physician Access – Overcome the difficulty in accessing your customers
• Incentive Compensation – Design and administer optimal incentive compensation plans
• Sales Training And Leadership – Implement successful training models to maximize your market share
• Data Analysis – Target high prescribing customers effectively through valuable data analysis methodologies
• Sales Force Technology – Augment your field sales force strategy using latest mobile and automation technology.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NAPRx®

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


NAPSR Named as Official Media Partner for Pharmaforce 2006

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Brad Sullivan - NAPSRonline.org 
1-800-913-0701 questions[.]napsronline.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NAPRx® securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NAPRx® / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)